Login / Signup

Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.

Christian M BeckerNeil P JohnsonSawsan As-SanieJuan C Arjona FerreiraMauricio Simões AbrãoKrzysztof WilkSo Jung ImmVandana MathurJulie S PerryRachel B WagmanLinda C Giudice
Published in: Human reproduction (Oxford, England) (2024)
NCT03654274.
Keyphrases
  • combination therapy
  • open label
  • chronic pain
  • clinical trial
  • pain management
  • phase ii
  • randomized controlled trial
  • squamous cell carcinoma
  • study protocol
  • radiation therapy
  • rectal cancer
  • double blind